Please Wait.....
Report
Castration-resistant Prostate Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2023-12-04 I 255 Pages I Infinium Global Research and Consulting Solutions
The report on the global castration-resistant prostate cancer treatment market provides qualitative and quantitative analysis for the period from 2021-2030. The global castration-resistant prostate cancer treatment market was valued at USD 10.11 billion in 2022 and is expected to reach USD 19.35 billion in 2030, with a CAGR of 8.51% during the forecast period 2023-2030. The study on castration-resistant prostate cancer treatment market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on castration-resistant prostate cancer treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global castration-resistant prostate cancer treatment market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global castration-resistant prostate cancer treatment market over the period of 2021-2030. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The development and introduction of novel treatments, such as targeted therapies and immunotherapies, drive growth in the castration-resistant prostate cancer treatment market.
- The increasing prevalence of castration-resistant prostate cancer fuels the market growth.
2) Restraints
- The high treatment costs pose a significant barrier to widespread adoption, limiting accessibility for patients and impacting market growth.
3) Opportunities
- Ongoing advancements in precision medicine and the identification of novel biomarkers for patient stratification offer a promising opportunities castration-resistant prostate cancer treatment market.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global castration-resistant prostate cancer treatment market is segmented on the basis of therapy type, drug delivery method, and distribution channel.
The Global Castration-resistant Prostate Cancer Treatment Market by Therapy Type
- Chemotherapy
- Hormonal Therapy
- Immunotherapy
- Radiotherapy
The Global Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
- Oral Route
- Injectable Route
The Global Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
The companies covered in the report include
- Pfizer Inc.
- Astellas Pharma Inc.
- Johnson & Johnson, Inc.
- Sanofi
- Novartis AG
- Bayer AG
- GSK plc.
- Northwest Biotherapeutics, Inc
- Active Biotech AB
- Dendreon Pharmaceuticals LLC.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the castration-resistant prostate cancer treatment market.
2. Complete coverage of all the segments in the castration-resistant prostate cancer treatment market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global castration-resistant prostate cancer treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Castration-resistant Prostate Cancer Treatment Market Highlights
2.2. Castration-resistant Prostate Cancer Treatment Market Projection
2.3. Castration-resistant Prostate Cancer Treatment Market Regional Highlights
Chapter 3. Global Castration-resistant Prostate Cancer Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Therapy Type
3.4.2. IGR-Growth Matrix Analysis by Drug Delivery Method
3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Castration-resistant Prostate Cancer Treatment Market
Chapter 4. Castration-resistant Prostate Cancer Treatment Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Castration-resistant Prostate Cancer Treatment Market
5.2. Companies Profiles
5.2.1. Pfizer Inc.
5.2.2. Astellas Pharma Inc.
5.2.3. Johnson & Johnson, Inc.
5.2.4. Sanofi
5.2.5. Novartis AG
5.2.6. Bayer AG
5.2.7. GSK plc.
5.2.8. Northwest Biotherapeutics, Inc
5.2.9. Active Biotech AB
5.2.10. Dendreon Pharmaceuticals LLC.
Chapter 6. Global Castration-resistant Prostate Cancer Treatment Market by Therapy Type
6.1. Chemotherapy
6.2. Hormonal Therapy
6.3. Immunotherapy
6.4. Radiotherapy
Chapter 7. Global Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
7.1. Oral Route
7.2. Injectable Route
Chapter 8. Global Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
8.1. Hospital Pharmacies
8.2. Retail Pharmacies
8.3. Online Pharmacies
Chapter 9. Global Castration-resistant Prostate Cancer Treatment Market by Region 2023-2030
9.1. North America
9.1.1. North America Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.1.2. North America Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.1.3. North America Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.1.4. North America Castration-resistant Prostate Cancer Treatment Market by Country
9.1.4.1. The U.S. Castration-resistant Prostate Cancer Treatment Market
9.1.4.1.1. The U.S. Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.1.4.1.2. The U.S. Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.1.4.1.3. The U.S. Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.1.4.2. Canada Castration-resistant Prostate Cancer Treatment Market
9.1.4.2.1. Canada Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.1.4.2.2. Canada Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.1.4.2.3. Canada Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.1.4.3. Mexico Castration-resistant Prostate Cancer Treatment Market
9.1.4.3.1. Mexico Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.1.4.3.2. Mexico Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.1.4.3.3. Mexico Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2. Europe
9.2.1. Europe Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.2. Europe Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.3. Europe Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2.4. Europe Castration-resistant Prostate Cancer Treatment Market by Country
9.2.4.1. Germany Castration-resistant Prostate Cancer Treatment Market
9.2.4.1.1. Germany Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.4.1.2. Germany Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.4.1.3. Germany Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2.4.2. United Kingdom Castration-resistant Prostate Cancer Treatment Market
9.2.4.2.1. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.4.2.2. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.4.2.3. United Kingdom Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2.4.3. France Castration-resistant Prostate Cancer Treatment Market
9.2.4.3.1. France Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.4.3.2. France Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.4.3.3. France Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2.4.4. Italy Castration-resistant Prostate Cancer Treatment Market
9.2.4.4.1. Italy Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.4.4.2. Italy Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.4.4.3. Italy Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.2.4.5. Rest of Europe Castration-resistant Prostate Cancer Treatment Market
9.2.4.5.1. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.2.4.5.2. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.2.4.5.3. Rest of Europe Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3. Asia Pacific
9.3.1. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.2. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.3. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4. Asia Pacific Castration-resistant Prostate Cancer Treatment Market by Country
9.3.4.1. China Castration-resistant Prostate Cancer Treatment Market
9.3.4.1.1. China Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.1.2. China Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.1.3. China Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4.2. Japan Castration-resistant Prostate Cancer Treatment Market
9.3.4.2.1. Japan Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.2.2. Japan Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.2.3. Japan Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4.3. India Castration-resistant Prostate Cancer Treatment Market
9.3.4.3.1. India Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.3.2. India Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.3.3. India Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4.4. South Korea Castration-resistant Prostate Cancer Treatment Market
9.3.4.4.1. South Korea Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.4.2. South Korea Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.4.3. South Korea Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4.5. Australia Castration-resistant Prostate Cancer Treatment Market
9.3.4.5.1. Australia Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.5.2. Australia Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.5.3. Australia Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.3.4.6. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market
9.3.4.6.1. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.3.4.6.2. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.3.4.6.3. Rest of Asia-Pacific Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.4. RoW
9.4.1. RoW Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.4.2. RoW Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.4.3. RoW Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.4.4. RoW Castration-resistant Prostate Cancer Treatment Market by Sub-region
9.4.4.1. Latin America Castration-resistant Prostate Cancer Treatment Market
9.4.4.1.1. Latin America Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.4.4.1.2. Latin America Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.4.4.1.3. Latin America Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.4.4.2. Middle East Castration-resistant Prostate Cancer Treatment Market
9.4.4.2.1. Middle East Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.4.4.2.2. Middle East Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.4.4.2.3. Middle East Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
9.4.4.3. Africa Castration-resistant Prostate Cancer Treatment Market
9.4.4.3.1. Africa Castration-resistant Prostate Cancer Treatment Market by Therapy Type
9.4.4.3.2. Africa Castration-resistant Prostate Cancer Treatment Market by Drug Delivery Method
9.4.4.3.3. Africa Castration-resistant Prostate Cancer Treatment Market by Distribution Channel
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security